The mechanism of inhibition of DNA synthesis in articular chondrocytes from young and old rats by nitric oxide

Nitric Oxide - Biology and Chemistry

Volumn 1, Issue 3, 1997, Pages 218-225

  Khatib, Abdel Majid ^a   Siegfried, Géraldine ^a   Quintero, Maritza ^a,b   Mitrovic, Dragoslav R ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Hospital Universitario de Los Andes   (Venezuela)

Author keywords

6 anilino 5,8 quinolinedione (LY 83583); Cyclic guanosine monophosphate (cGMP); DNA synthesis; Indomethacin; N(G)monomethyl L arginine; Prostaglandin E2

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; CYCLIC GMP; INDOMETACIN; ISOSORBIDE DINITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN E2; THYMIDINE;

ANIMAL CELL; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL METABOLISM; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; NONHUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RAT; SENESCENCE;

ANIMALIA;

EID: 0031424469     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1997.0126     Document Type: Article

References (30)

1. Marletta M. A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:1993;12231-12234.
2. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
3. Culotta E., Koshland D. E. Molecule of the year: NO news is good news. Science. 258:1992;1861-1864.
4. Rapoport R. M. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidyl inositol hydrolysis in rat aorta. Circ. Res. 58:1986;407-410.
5. Ignarro L. J., Kadowitz P. J. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol. 25:1985;171-191.
6. Feelisch M., Noack E. A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. J. Pharmacol. 139:1987;19-30.
7. Farrell A. J., Blake D. R., Palmer R. M., Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51:1992;1219-1222.
8. Rediske J. J., Koehne C. F., Zhang B., Lotz M. The inducible production of nitric oxide by articular cell types. Osteoarthritis Cartilage. 2:1994;199-206.
9. Stadler J., Stefanovic-Racic M., Billiar T. R., Curran R. D., McIntyre L. A., Georgescu H. I., Simmons R. L., Evans C. H. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol. 147:1991;3915-3920.
10. Hauselmann H. J., Oppliger L., Michel B. A., Stefanovic-Racic M., Evans C. H. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett. 352:1994;361-364.
11. Golstein S. Replicative senescence: The human fibroblast comes of age. Science. 249:1990;1129-1133.
12. Philips P. D., Kaji K., Cristofalo V. J. Progressive loss of the proliferative response of senescing WI-38 cells to platelet-derived growth factor, epidermal growth factor, insulin, transferin, and dexamethasone. Gerontology. 39:1984;11-17.
13. Cristofalo V. J., Pignollo R. J., Rotenberg M. O. Molecular changes with in vitro cellular senescence. Ann. NY Acad. Sci. 663:1992;187-194.
14. Ribault D., Khatib A.-M., Barbara A., Bouizar Z., Mitrovic R. D. Mitogenic and metabolic actions of epidermal growth factor on rat articular chondrocytes: Modulation by fetal calf serum, transforming growth factor-β, and tyrphostin. Arch. Biochem. Biophys. 337:1997;149-158.
15. Cesar L., Kenneth P. A. Simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:1980;344-352.
16. Mûlsch A., Busse R., Liebau S., Förstermann U. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation. J. Pharmacol. Exp. Ther. 247:1988;283-288.
17. Gerzer R., Karrenbrock B., Siess W., Heim J. M. Direct comparison of the effect of nitroprusside, SIN-1 and various nitrates on platelet aggregation and soluble guanylyl cyclase activity. Thromb. Res. 52:1988;11-21.
18. Henry Y., Lepoivre M., Drapier J. C., Ducrocq C., Boucher J. L., Guissani A. Characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7:1993;1124-1134.
19. Wink D. A., Kasprzak K. S., Maragos C. M., Elespuru R. K., Misra M., Dunams T. M., Cebula T. A., Koch W. H., Andrews A. W., Allen J. S., Keefer L. K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1991;1001-1003.
20. Nguyen T., Brunson D., Crespi C. L., Penman B. W., Wishnok J. S., Tannenbaum S. R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA. 89:1992;3030-3034.
21. Lepoivre M., Cherais B., Yapo A., Lemaure G., Thelander L., Tenu J. P. J. Alterations of ribonucleotide reductase activity following induction of the nitrite generating pathway in adenocarcinoma cells. J. Biol. Chem. 265:1990;14143-14149.
22. 2. Exp. Cel Res. 218:1995;319-325.
23. Nakaki T., Nakayama M., Kato R. Inhibition by nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol. 189:1990;347-353.
24. Garg U. C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1989;1774-1777.
25. Owen N. E. Effect of TPA on ion flux and DNA synthesis in vascular smooth muscle cells. J. Cell Biol. 101:1985;454-459.
26. Kato J., Lanier-Smith K. L., Currie M. G. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells. J. Biol. Chem. 266:1991;14681-14685.
27. Seshachi J., Campisi J. Repression of c-fos-transcription and an altered genetic program in senescent human fibroblasts. Science. 247:1990;205-208.
28. Haby C., Lisovoski F., Aunis D., Zwiller J. Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and jun B in PC12 cells. J. Neurochem. 62:1994;496-501.
29. 12. Mol. Pharmacol. 37:1990;30-36.
30. 2+2+. J. Biol. Chem. 264:1989;1146-1155.